company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q4,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1428000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1428000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,83000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-7000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,763000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-589000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q4,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-589000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,14020000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,61000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,50000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q4,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14131000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q4,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14131000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,664000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,664000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q4,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,664000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q4,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14206000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2013.0,Q4,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,12000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7064000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7064000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,79000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5139000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-111000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1957000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1957000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4004000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-75000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,921000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,921000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,1000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q1,2013-07-01,2013-09-30,2014-11-12 16:17:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1036000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-735000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-735000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,82000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2085000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1526000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1212000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1212000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,4004000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,75000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,20554000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,87000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10500000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,35220000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,35220000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,-1000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2014.0,Q2,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,34008000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5381000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5381000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,89000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,407000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,844000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4041000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4041000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-38205000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-30000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,48450000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10215000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10215000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,32039000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,32039000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,32039000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 16:04:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,38213000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4650000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4650000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,95000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,821000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-340000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4074000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4074000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-38545000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-27000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,40000000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1428000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1428000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-30000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,69000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,39000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,39000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q2,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2607000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6326000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6326000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,95000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,892000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,378000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4961000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4961000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14533000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-11000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19680000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5136000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5136000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,79000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,79000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,79000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q3,2015-01-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,254000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7961000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7961000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,97000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,158000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,700000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,597000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6409000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6409000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11806000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-30000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12949000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1113000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1113000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2015.0,Q4,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5296000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9123000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9123000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,97000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1759000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,102226000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,94959000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,94959000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26072000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-55000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13030000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13097000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13097000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,19211000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,19211000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,19211000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q1,2015-07-01,2015-09-30,2016-11-08 16:02:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,101073000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3045000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3045000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,99000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1366000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13225000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8715000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8715000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-94662000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-30000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7314000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-87378000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-87378000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,235000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,235000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,235000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q2,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-95858000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1969000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1969000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,179000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1405000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11407000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7854000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7854000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-29724000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-20000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11080000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18664000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18664000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q3,2016-01-01,2016-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-26518000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2728000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2728000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,192000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,448000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1113000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11880000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7399000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7399000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-60193000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-16000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,78544000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18335000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18335000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,283000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-235000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,48000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,48000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2016.0,Q4,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10984000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3025000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3025000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,201000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,200000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1420000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10641000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5795000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5795000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2421000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-49000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,35358000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,32888000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,32888000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,19000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,19000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,19000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q1,2016-07-01,2016-09-30,2017-11-07 17:05:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,27112000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1779000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1779000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,233000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,16000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1492000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10513000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6993000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6993000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-35361000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-43000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,28911000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6493000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6493000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q2,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13481000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1199000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1199000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,223000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,104000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1249000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8596000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8219000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8219000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13295000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-40000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2000000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16552000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1217000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1217000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,27000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-24000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q3,2017-01-01,2017-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6999000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3198000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3198000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,255000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,82000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1492000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8625000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9994000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9994000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-17204000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-20000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22423000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5199000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5199000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4794000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2017.0,Q4,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,887000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1397000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1397000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,234000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,82000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1469000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9039000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8651000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8651000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-130000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,26807000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,26677000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,26677000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,18028000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q1,2017-07-01,2017-09-30,2018-11-09 16:28:03+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,670000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5190000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5190000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,310000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,61000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1331000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6361000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9849000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9849000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,31477000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-18000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-17000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-17000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q2,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21611000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8101000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8101000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,277000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,31000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1666000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1150000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7277000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7277000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15404000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-17000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-3000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-31000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-31000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q3,2018-01-01,2018-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22712000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6612000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6612000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,354000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-89000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1249000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1645000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6743000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6743000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22311000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-141000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12717000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9735000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9735000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-14000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-85000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-90000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-90000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16568000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2018.0,Q4,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-53000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1200000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1200000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,321000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-142000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,820000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1616000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,583000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,583000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-29763000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-23000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24736000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5050000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5050000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-13000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-113000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-126000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-126000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q1,2018-07-01,2018-09-30,2019-11-12 16:53:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4593000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4181000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4181000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,318000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-211000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1216000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6701000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9559000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9559000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14841000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-45000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21883000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6997000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6997000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-13000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-55000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,136000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,68000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,68000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q2,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2494000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11489000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11489000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,318000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-225000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,855000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-19381000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6944000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6944000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20343000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-80000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25000000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4577000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4577000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,26000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-136000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,69000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-41000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-41000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q3,2019-01-01,2019-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2408000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10514000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10514000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,316000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-212000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,815000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2058000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7537000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7537000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9997000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22500000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12503000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12503000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-52000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,168000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,156000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-105000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,167000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,167000.0
Applied Genetic Technologies Corp,AGTC,549300I3X9WJZYN79L35,0001273636,2019.0,Q4,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5133000.0
